司来吉兰 盐酸盐
司来吉兰 盐酸盐结构式
|
常用名 | 司来吉兰 盐酸盐 | 英文名 | selegiline |
|---|---|---|---|---|
| CAS号 | 14611-51-9 | 分子量 | 187.28100 | |
| 密度 | 0.954g/cm3 | 沸点 | 272.5ºC at 760 mmHg | |
| 分子式 | C13H17N | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 108.4ºC | |
| 符号 |
GHS02, GHS06, GHS08 |
信号词 | Danger |
司来吉兰 盐酸盐用途Selegiline is a selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson's disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. (From AMA Drug Evaluations Annual, 1994, p385) The compound without isomeric designation is Deprenyl. |
| 中文名 | 司来吉兰 盐酸盐 |
|---|---|
| 英文名 | (-)-selegiline |
| 中文别名 | 司来吉兰 |
| 英文别名 | 更多 |
| 密度 | 0.954g/cm3 |
|---|---|
| 沸点 | 272.5ºC at 760 mmHg |
| 分子式 | C13H17N |
| 分子量 | 187.28100 |
| 闪点 | 108.4ºC |
| 精确质量 | 187.13600 |
| PSA | 3.24000 |
| LogP | 2.18260 |
| 蒸汽压 | 0.00606mmHg at 25°C |
| 折射率 | 1.528 |
| 储存条件 | 2-8°C，密封，干燥 |
| 符号 |
GHS02, GHS06, GHS08 |
|---|---|
| 信号词 | Danger |
| 危害声明 | H225-H301 + H311 + H331-H370 |
| 警示性声明 | P210-P260-P280-P301 + P310-P311 |
| 危害码 (欧洲) | F,T |
| 风险声明 (欧洲) | 11-23/24/25-39/23/24/25 |
| 安全声明 (欧洲) | 7-16-36/37-45 |
| 危险品运输编码 | UN 1851 |
| 包装等级 | III |
| 危险类别 | 6.1(b) |
| 海关编码 | 2921499090 |
| 海关编码 | 2921499090 |
|---|---|
| 中文概述 | 2921499090 其他芳香单胺及衍生物及它们的盐. 增值税率:17.0% 退税率:9.0% 监管条件:无 最惠国关税:6.5% 普通关税:30.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | 2921499090 other aromatic monoamines and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
|
Design and application of an in vivo reporter assay for phenylalanine ammonia-lyase.
Appl. Microbiol. Biotechnol. 97(17) , 7877-85, (2013) Phenylalanine ammonia-lyase (PAL) is an important enzyme that links primary metabolism to secondary metabolism. Its efficiency is often a critical factor that affects the overall flux of a related met... |
|
|
A (p)ppGpp-null mutant of Haemophilus ducreyi is partially attenuated in humans due to multiple conflicting phenotypes.
Infect. Immun. 82(8) , 3492-502, (2014) (p)ppGpp responds to nutrient limitation through a global change in gene regulation patterns to increase survival. The stringent response has been implicated in the virulence of several pathogenic bac... |
|
|
Mutational analysis of the (p)ppGpp synthetase activity of the Rel enzyme of Mycobacterium tuberculosis.
Arch. Microbiol. 196(8) , 575-88, (2014) Rel(Mtb), a GTP pyrophosphokinase encoded by the Mycobacterium tuberculosis (Mtb) genome, catalyzes synthesis of (p)ppGpp from ATP and GDP(GTP) and its hydrolysis to GDP(GTP) and pyrophosphate to medi... |
| Eldepryl |
| Jumex |
| (2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine |
| N-methyl-N-((R)-1-phenylpropan-2-yl)prop-2-yn-1-amine |
| Selegilina |
| Emsam |
| L-Deprenalin |
| Carbex |
| methyl(1-phenylpropan-2-yl)(prop-2-yn-1-yl)amine |
| Selegilinum |
| (S)-(+)-selegiline |
| Selegyline |
| Zelapar |
